JP2010510278A - 新規抗コリン作用薬を含有する安定な粉末製剤 - Google Patents

新規抗コリン作用薬を含有する安定な粉末製剤 Download PDF

Info

Publication number
JP2010510278A
JP2010510278A JP2009537589A JP2009537589A JP2010510278A JP 2010510278 A JP2010510278 A JP 2010510278A JP 2009537589 A JP2009537589 A JP 2009537589A JP 2009537589 A JP2009537589 A JP 2009537589A JP 2010510278 A JP2010510278 A JP 2010510278A
Authority
JP
Japan
Prior art keywords
acid
anion
spray
powder formulation
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009537589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510278A5 (https=
Inventor
ミハエル トルンク
クラウディウス ヴァイラー
ヴェルナー ピーロート
Original Assignee
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2010510278A publication Critical patent/JP2010510278A/ja
Publication of JP2010510278A5 publication Critical patent/JP2010510278A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2009537589A 2006-11-22 2007-11-06 新規抗コリン作用薬を含有する安定な粉末製剤 Pending JP2010510278A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124578A EP1925296A1 (de) 2006-11-22 2006-11-22 Stabile Pulverformulierung enthaltend ein neues Anticholinergikum
PCT/EP2007/061910 WO2008061873A2 (de) 2006-11-22 2007-11-06 Stabile pulverformulierung enthaltend ein neues anticholinergikum

Publications (2)

Publication Number Publication Date
JP2010510278A true JP2010510278A (ja) 2010-04-02
JP2010510278A5 JP2010510278A5 (https=) 2010-12-24

Family

ID=38110605

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009537589A Pending JP2010510278A (ja) 2006-11-22 2007-11-06 新規抗コリン作用薬を含有する安定な粉末製剤

Country Status (5)

Country Link
US (1) US20100047359A1 (https=)
EP (2) EP1925296A1 (https=)
JP (1) JP2010510278A (https=)
CA (1) CA2670153A1 (https=)
WO (1) WO2008061873A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011502102A (ja) * 2006-11-22 2011-01-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬を含有する安定な粉末製剤

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT107312B (pt) * 2013-11-25 2022-05-10 Advanced Cyclone Systems S A Ciclone aglomerador de fluxo invertido e respectivo processo
CN111533959B (zh) * 2020-05-25 2021-11-23 上海邦成生物工程有限公司 低聚壳聚糖/木薯淀粉复合丙酸锌固形物及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507702A (ja) * 1996-12-31 2001-06-12 インヘイル・セラピューティックス・システムズ・インコーポレテッド 親水性賦形剤を有する疎水性薬剤の水性懸濁液を噴霧乾燥させる方法およびその方法によって作製された組成物
WO2005080338A2 (en) * 2004-02-20 2005-09-01 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2003024396A2 (en) * 2001-09-17 2003-03-27 Glaxo Group Limited Dry powder medicament formulations
DE10203741A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US20050112087A1 (en) * 2003-04-29 2005-05-26 Musso Gary F. Pharmaceutical formulations for sustained drug delivery
US7462367B2 (en) * 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
DE10331350A1 (de) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum
WO2005079794A1 (en) * 2004-02-20 2005-09-01 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on anticholinergics and pegsunercept

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507702A (ja) * 1996-12-31 2001-06-12 インヘイル・セラピューティックス・システムズ・インコーポレテッド 親水性賦形剤を有する疎水性薬剤の水性懸濁液を噴霧乾燥させる方法およびその方法によって作製された組成物
WO2005080338A2 (en) * 2004-02-20 2005-09-01 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011502102A (ja) * 2006-11-22 2011-01-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬を含有する安定な粉末製剤

Also Published As

Publication number Publication date
EP2094245A2 (de) 2009-09-02
EP1925296A1 (de) 2008-05-28
WO2008061873A3 (de) 2008-07-10
CA2670153A1 (en) 2008-05-29
US20100047359A1 (en) 2010-02-25
WO2008061873A2 (de) 2008-05-29

Similar Documents

Publication Publication Date Title
CA2216828C (en) Controlled release insufflation carrier for medicaments
CA2481876C (en) Inhalation kit comprising inhalable powder of tiotropium
KR101639098B1 (ko) 폐 질환 치료용 건조 분말 제형 및 방법
WO1999027911A1 (fr) Medicament en pastilles souples et procede de fabrication
US20170326150A1 (en) Stable powder formulation containing an anticholingeric agent
KR20100095437A (ko) 아스코르브산 유도체를 포함하는 건조 분말 제제
AU2006220411A1 (en) Inhalable Sustained Therapeutic Formulations
JP2010510278A (ja) 新規抗コリン作用薬を含有する安定な粉末製剤
MXPA06014502A (es) Reduccion de retencion de polvo en superficies.
WO2014205031A1 (en) Sustained-release formulation of rotigotine
US20240180897A1 (en) Methods and compositions for treating pulmonary hypertension
US20250205153A1 (en) Inhalation composite and carrier based formulation combination
KR20230152083A (ko) 다이하이드로에르고타민 건조 분말 제형 및 사용 방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101105

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121105

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130130

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130502

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130701